IL-17 Augments B Cell Activation in Ocular Surface Autoimmunity

Area of Science:

• Immunology
• Autoimmunity
• Ophthalmology

Background:

• Interleukin-17 (IL-17) is implicated in various autoimmune conditions.
• The precise role of IL-17 in the humoral immune response, particularly B cell activation and differentiation, remains incompletely understood.
• Dry eye disease serves as a relevant preclinical model for studying IL-17-mediated autoimmune pathology.

Purpose of the Study:

• To investigate the specific effects of IL-17 on B cell responses within the context of autoimmune dry eye disease.
• To elucidate the mechanisms by which IL-17 influences B cell proliferation, differentiation, and germinal center formation.
• To assess the therapeutic potential of targeting IL-17 in this disease model.

Main Methods:

• Utilized a preclinical model of IL-17-mediated dry eye disease.
• Analyzed B cell proliferation, germinal center formation, and differentiation into plasma cells.
• Compared the B cell help provided by T helper 17 (Th17) cells versus T helper 1 (Th1) cells.
• Administered in vivo IL-17A neutralization to evaluate clinical disease impact.

Main Results:

• IL-17 enhances B cell proliferation and germinal center formation, contingent on antigen-dependent T-B cell interactions.
• IL-17 promotes B cell differentiation into isotype-switched B cells and plasma cells.
• Th17 cells demonstrate superior B cell help compared to Th1 cells.
• In vivo IL-17A neutralization led to a significant reduction in clinical disease severity, correlating with reduced B cell responses.

Conclusions:

• IL-17 plays a direct role in promoting autoimmune responses by enhancing B cell proliferation and differentiation.
• IL-17 contributes to the generation of plasma cells, key players in antibody-mediated autoimmunity.
• Targeting IL-17 offers a potential therapeutic strategy for autoimmune diseases characterized by humoral immune dysregulation.